Cargando…
Cellular and vaccine therapeutic approaches for gliomas
Despite new additions to the standard of care therapy for high grade primary malignant brain tumors, the prognosis for patients with this disease is still poor. A small contingent of clinical researchers are focusing their efforts on testing the safety, feasibility and efficacy of experimental activ...
Autores principales: | , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2964608/ https://www.ncbi.nlm.nih.gov/pubmed/20946667 http://dx.doi.org/10.1186/1479-5876-8-100 |